(-)-Epigallocatechin-3-gallate inhibits VEGF expression induced by IL-6 via Stat3 in gastric cancer.
about
Recent updates of precision therapy for gastric cancer: Towards optimal tailored managementCancer prevention with promising natural products: mechanisms of action and molecular targetsPrevention of colitis-associated cancer: natural compounds that target the IL-6 soluble receptorChemoprevention of gastrointestinal cancer: the reality and the dream.Pancreatic cancer chemoprevention by phytochemicalsImprovement in insulin resistance and favourable changes in plasma inflammatory adipokines after weight loss associated with two months' consumption of a combination of bioactive food ingredients in overweight subjects.Preparation of epigallocatechin gallate-loaded nanoparticles and characterization of their inhibitory effects on Helicobacter pylori growth in vitro and in vivo.Targeting STAT3 in gastric cancer.Green tea catechins: a fresh flavor to anticancer therapy.Dietary phytochemicals alter epigenetic events and signaling pathways for inhibition of metastasis cascade: phytoblockers of metastasis cascade.Interleukin-6 trans-signalling induces vascular endothelial growth factor synthesis partly via Janus kinases-STAT3 pathway in human mesothelial cells.Effects of caffeic acid phenethyl ester on matrix molecules and angiogenetic and anti-angiogenetic factors in gastric cancer cells cultured on different substrates.(-)-Epigallocatechin-3-gallate inhibits nasopharyngeal cancer stem cell self-renewal and migration and reverses the epithelial-mesenchymal transition via NF-κB p65 inactivation.Absorption, metabolism, anti-cancer effect and molecular targets of epigallocatechin gallate (EGCG): An updated review.Expression of p-STAT3 and vascular endothelial growth factor in MNNG-induced precancerous lesions and gastric tumors in rats(-)-Epigallocatechin-3-gallate inhibits human papillomavirus (HPV)-16 oncoprotein-induced angiogenesis in non-small cell lung cancer cells by targeting HIF-1α.Necl 4 and RNase 5 Are Important Biomarkers for Gastric and Colon Adenocarcinomas.Antiangiogenic Effect of Flavonoids and Chalcones: An Update.
P2860
Q26746246-A1C4E38D-90DB-4A0A-B367-F15CECD5DBBAQ27006530-6FD445EA-731F-4721-85B4-9CF0313C939FQ27022976-D650204B-C77B-4578-B7C3-F41EDBCDA1F1Q36715105-06C27F35-236D-49C9-9BCE-946759C53A52Q36763100-63195378-9C15-46F3-BB0A-684A58FFF233Q37214530-73C82A9E-AD56-4901-874C-1D65875FACCAQ37387057-C265FA90-23CD-4C14-A9A7-E9DE50006096Q38029729-D85767D3-E67E-4390-9824-D75E5D49FE6CQ38147993-C7BA17D4-38D4-405F-BAF3-66028AD91D0FQ38175845-C08D4B59-1B4F-4B82-B8DB-8BFB1903D125Q38794840-1F54CFA0-E82F-40B8-B01E-0AF25A800FAEQ38822991-60FE11BE-265B-4ED7-A2C2-BB54C0EC4624Q38930822-38755EFB-DF61-40E4-B23D-AFAC11CF3FBDQ38958946-24FDBB36-1788-4078-8E92-397966A3C4F7Q38965315-28A59C03-042D-44D0-AB7F-45DD13AEA154Q39215796-B4FC22E3-2E5D-475C-97D0-AFDF5C22D986Q42217300-9C131E81-1A77-42A9-A1DC-6FA6FF319DDDQ50043004-BCFB3BAC-009C-4B46-AED1-7C532A8DCAF3
P2860
(-)-Epigallocatechin-3-gallate inhibits VEGF expression induced by IL-6 via Stat3 in gastric cancer.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
(-)-Epigallocatechin-3-gallate ...... 6 via Stat3 in gastric cancer.
@ast
(-)-Epigallocatechin-3-gallate ...... 6 via Stat3 in gastric cancer.
@en
type
label
(-)-Epigallocatechin-3-gallate ...... 6 via Stat3 in gastric cancer.
@ast
(-)-Epigallocatechin-3-gallate ...... 6 via Stat3 in gastric cancer.
@en
prefLabel
(-)-Epigallocatechin-3-gallate ...... 6 via Stat3 in gastric cancer.
@ast
(-)-Epigallocatechin-3-gallate ...... 6 via Stat3 in gastric cancer.
@en
P2093
P2860
P356
P1476
(-)-Epigallocatechin-3-gallate ...... 6 via Stat3 in gastric cancer.
@en
P2093
Bao-He Zhu
Chang-Hua Zhang
Cheng-You Wang
Hua-Yun Chen
Shi-Rong Cai
Wen-Hua Zhan
Yu-Long He
P2860
P304
P356
10.3748/WJG.V17.I18.2315
P407
P577
2011-05-01T00:00:00Z